Skip to Content

Tag: Vyjuvek

John Rademacher

Also Noted

Option Care nabs exclusive distribution contract for Vyjuvek

May 24, 2023HME News Staff

BANNOCKBURN, Ill. – Option Care Health has been selected by Krystal Biotech as part of a limited distribution specialty pharmacy network for Vyjuvek, which was recently approved by the U.S. Food & Drug Administration for the treatment of patients with dystrophic epidermolysis bullosa (DEB). Through its national footprint of more than 95 specialty pharmacies, Option Care will serve as the only specialty pharmacy provider for mixing and delivering prepared Vyjuvek gel administration syringes...

Option Care, Vyjuvek

Read Full Articlered right arrow icon